[Skip to Content]
[Skip to Content Landing]
From the JAMA Network
April NaN, 2014

Serum Brain-Derived Neurotrophic Factor and the Risk for Dementia

Author Affiliations
  • 1Department of Neurosciences, University of California, San Diego, La Jolla
JAMA. 2014;311(16):1684-1685. doi:10.1001/jama.2014.3120

In view of the substantially increasing epidemic of Alzheimer disease (AD), efforts to find and explain genetic, biological, and environmental influences on the risk of AD are essential. The Framingham Heart Study (FHS) is the exemplar of long-term community-based studies and, despite some limitations involving generalizability, provides a rich opportunity for investigation of AD risk factors,1 including peripheral blood biomarkers of risk. The findings of such research can guide therapeutic trials, improving the likelihood of success in finding preventive and disease-slowing interventions.

First Page Preview View Large
First page PDF preview
First page PDF preview